Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00514111
Status:
COMPLETED
Last Update Posted:
2009-03-20
First Post:
2007-08-08
Brief Title:
Factors Associated to Success of Hepatitis C Therapy
Sponsor:
UPECLIN HC FM Botucatu Unesp
Organization:
UPECLIN HC FM Botucatu Unesp
Study Overview
Official Title:
Factors Associated to Success of Hepatitis C Therapy
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to evaluate the sustained virologic response RVS in HVC patients treated with pegylated-interferon or conventional-interferon and ribavirin and to investigate the associated factors with RVS by means of retrospective analysis
Detailed Description:
Chronic hepatitis C virusHVC is a major public-health problem since it presents a long phase of clinical latency which makes its early diagnosis difficult and results in the development of a large number of cases to complications such as cirrhosis hepatic insufficiency and hepatocarcinoma In Brazil it is estimated three million estimated cases to 52 thousand reports The aim of this study is to evaluate the sustained virologic response RVS in HVC patients treated with pegylated-interferon or conventional-interferon and ribavirin and to investigate the associated factors with RVS by means of retrospective analysis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None